$STX

Lee James CI sold $609K of STX

Lee James CI (EVP & CLO) sold 694 shares of Seagate Technology Holdings plc (STX) at $877.45 ($0.61M total) on 2026-07-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lee James CI
Published Aug 3, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:14 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$STX
Neutral
high confidence
Mentioned
$STX
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$STXNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and post-transaction holdings under a pre-arranged 10b5-1 plan; it does not include any new Seagate operational or financial information.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 framing and lack of fundamental updates make it low priority versus earnings, guidance, or contract/regulatory news.

03

What to watch

The article does not state whether other insiders sold/bought, nor does it provide total insider activity context; without that, the signal is weak.

Relevance 4/10Novelty 3/10Timing: filed Aug 3, 2026 for a July 30 sale

Background

The article is a SEC Form 4 insider transaction disclosure for Seagate Technology Holdings plc (STX).

Company-level read

Ticker impact

$STXNeutralHigh confidence
Context

Seagate Form 4 shows EVP & CLO Lee James CI sold 694 shares at $877.45 under a pre-arranged 10b5-1 plan, reducing holdings to 347.

Expected impact

Low near-term impact; any reaction is likely limited to short-lived sentiment around insider selling.

Evidence & confidence

The filing is a Form 4 open-market sale explicitly tied to a pre-arranged 10b5-1 plan, and the article provides no new company-specific business development.

Market effects

Minimal; insider 10b5-1 sales typically do not reset sector expectations.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can be interpreted by some traders as a signal of reduced confidence, especially if paired with other negative disclosures.

Key entities

  • Seagate Technology Holdings plc

    Subject of the Form 4 insider transaction disclosure.

  • Lee James CI

    EVP & CLO who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVDAHighAI 9/10

Markets News, Aug. 27, 2026: Nvidia Stock Powers Higher After Earnings, Driving Tech Gains; Nasdaq Closes Sharply Higher

Nvidia (NVDA) reported strong Q2 earnings and raised Q3 revenue guidance to $108B, driving its stock up 9% and boosting tech sector gains. Nasdaq, S&P 500, and Dow closed higher. Other notable movers include Okta (OKTA) +29%, Salesforce (CRM) +23%, and CrowdStrike (CRWD) +20%. Corporate profits surged $400B in Q2, partly due to $71B in tariff refunds.

$STXMed

Moody’s upgrades Seagate Data rating on AI demand strength

Moody's upgraded Seagate Data's corporate family rating to Ba1 from Ba2, citing AI-driven demand for high-capacity HDDs. The agency expects revenues to grow over 30% annually, reaching $20B, and debt to EBITDA to fall below 0.5x. Seagate faces risks from revenue concentration and pricing pressures. The company had $1.7B in cash and access to a $1.3B credit facility as of July 2026.

$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

$STXMed

REG - Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US

Shield Therapeutics (STX) will take full control of ACCRUFeR® in the US from Viatris by September 30, 2026. The deal is expected to boost Shield's profitability and growth, with no upfront payments to Viatris. Shield will pay royalties on US net sales, ranging from high single digits to mid-teens over five years, and retain all gross profits from US sales. The transaction is anticipated to enhance Shield's financial profile and support its path to sustained profitability.